PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'School of Biomedical Sciences and Pharmacy, The University of Newcastle, Callaghan, Australia.\', \'School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia.\', \'School of Postgraduate Studies, International Medical University School of Medicine, Kuala Lumpur, Malaysia.\', \'School of Pharmacy, Monash University Malaysia, Jalan Lagoon Selatan, Bandar Sunway, Petaling Jaya, Selangor, Malaysia.\', \'School of Pharmacy, Institute of Clinical Sciences, University of Birmingham, Birmingham, United Kingdom of Great Britain and Northern Ireland.\', \'School of Applied Sciences, University of Huddersfield, Huddersfield, United Kingdom of Great Britain and Northern Ireland.\', \'School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, Australia.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1080/14787210.2021.1949984
?:doi
?:hasPublicationType
?:journal
  • Expert review of anti-infective therapy
is ?:pmid of
?:pmid
?:pmid
  • 34192469
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.264
?:rankingScore_hIndex
  • 62
?:title
  • The use of remdesivir for the management of patients with moderate-to-severe COVID-19: a systematic review.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34192469>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34192469>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all